BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced that Nathan Fowler, MD, Chief Medical Officer at BostonGene will deliver multiple presentations ...

H2Ocean proudly participated in the 4th International Conference on Cancer Health Disparities (ICCHD) & 9th Annual ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue. A new “Tumor Activated Therapy™” in development at the small ...

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.

A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast ...